Can a palliative care team boost quality of life for cancer surgery patients?
NCT ID NCT03611309
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether having a palliative care team work alongside surgeons improves quality of life for patients with gastrointestinal cancers like pancreatic or liver cancer. About 379 patients and their family members took part. The main goal was to see if this team approach leads to better well-being 12 weeks after surgery compared to standard surgeon-only care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- palliative care team co-management
- What this could lead to
- If successful, this approach could improve quality of life and emotional well-being for patients and families facing major cancer surgery.
- What could go wrong
- This is a completed trial, but the intervention is supportive care, not a cure. Benefits may be modest and not apply to all cancer types or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dana Farber/ Brigham
Boston, Massachusetts, 02115, United States
-
Johns Hopkins Hostpital
Baltimore, Maryland, 21287, United States
-
Ohio State University Medical Center
Columbus, Ohio, 43210, United States
-
Stanford University
Stanford, California, 94304, United States
-
University of New Mexico
Albuquerque, New Mexico, 87131, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication